Literature DB >> 10625593

Quality control of MHC class II associated peptides by HLA-DM/H2-M.

A B Vogt1, S O Arndt, G J Hämmerling, H Kropshofer.   

Abstract

For many years the crucial components involved in MHC class II mediated antigen presentation have been thought to be known: polymorphic MHC class II molecules, the monomorphic invariant chain (li) and a set of conventional proteases that cleave antigenic proteins thereby generating ligands able to associate with MHC class II molecules. However, in 1994 it was found that without an additional molecule, HLA-DM (DM), efficient presentation of protein antigens cannot be achieved. Biochemical studies showed that DM acts as a molecular chaperone protecting empty MHC class II molecules from functional inactivation. In addition, it serves as a peptide editor: DM catalyzes not only the release of the invariant chain remnant CLIP, but of all sorts of low-stability peptides, and simultaneously favors binding of high-stability peptides. Through this quality control of peptide loading, DM enables APCs to optimize MHC restriction and to display their antigenic peptide cargo on the surface for prolonged periods of time to be scrutinized by T cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10625593     DOI: 10.1006/smim.1999.0197

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  6 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

2.  Is tapasin a modified Mhc class I molecule?

Authors:  W E Mayer; J Klein
Journal:  Immunogenetics       Date:  2001-12-18       Impact factor: 2.846

Review 3.  Generation of MHC class II-peptide ligands for CD4 T-cell allorecognition of MHC class II molecules.

Authors:  Scott A Leddon; Andrea J Sant
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

4.  Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin.

Authors:  Katherine A Richards; Francisco A Chaves; Frederick R Krafcik; David J Topham; Christopher A Lazarski; Andrea J Sant
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

5.  Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.

Authors:  Xiaofeng Yin; Quansheng Wu; Zheng Hao; Laizhao Chen
Journal:  Biomed Eng Online       Date:  2022-04-18       Impact factor: 3.903

Review 6.  The control of the specificity of CD4 T cell responses: thresholds, breakpoints, and ceilings.

Authors:  Andrea J Sant; Francisco A Chaves; Scott A Leddon; Jacqueline Tung
Journal:  Front Immunol       Date:  2013-10-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.